Literature DB >> 3013124

Hepatocellular carcinoma presenting with intractable diarrhea. A radiologic-pathologic correlation.

E Steiner, P Velt, O Gutierrez, S Schwartz, W Chey.   

Abstract

A 44-year-old woman with hepatocellular carcinoma presented with intractable watery diarrhea and her condition was evaluated angiographically. Surgical ablation of the tumor resulted in complete resolution of the diarrhea. The tumor cells of the hepatocellular carcinoma were found to contain vasoactive intestinal polypeptide, gastrin, and prostaglandinlike immunoactivity. To our knowledge, this is the first report of such an association.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013124     DOI: 10.1001/archsurg.1986.01400070119025

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

Review 1.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

2.  Diarrhea as a presenting symptom of hepatocellular carcinoma.

Authors:  J Bruix; A Castells; X Calvet; F Feu; C Bru; M Solé; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

3.  Diagnosis of hepatocellular carcinoma.

Authors:  Eldad S Bialecki; Adrian M Di Bisceglie
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 4.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 5.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.